Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

Immunotherapy is the only treatment for allergy that has the potential to alter the natural
course of the disease. Sublingual immunotherapy for grass pollen-induced …

Background Allergen‐specific immunotherapy (SIT) with native allergen extracts and
allergoids has been performed successfully for decades. Preliminary studies revealed the …

Different vaccines containing intact allergens or chemically modified allergoids as active
ingredients are commercially available for specific immunotherapy. Allergoids are claimed to …

Objective: A double-blind, placebo-controlled study was performed with 37 patients to
assess the efficacy as well as the safety of short-term pre-seasonal subcutaneous …

Background The optimal dose (300IR) of a five‐grass pollen sublingual immunotherapy
tablet in terms of efficacy was previously demonstrated from the first pollen season …

Allergic diseases constitute a major health issue worldwide. Mainstay treatment constitutes
allergen avoidance and pharmacotherapy for symptom relief, but allergen immunotherapy …

Background Injective immunotherapy is a well‐known and recognized treatment for allergic
diseases, but its safety has been questioned during recent years. Alternative administration …

BACKGROUND: Immunotherapy with the standardized quality grass tablet Grazax is
efficacious and well-tolerated in adult patients with rhinoconjunctivitis. Allergic asthma and …

BACKGROUND: Subcutaneous allergen-specific immunotherapy is an effective treatment of
IgE-mediated allergies, but it requires repeated allergen injections with a risk of systemic …